GlaxoSmithKline (NYSE: GSK) reported Q1 EPS of GBP0.19, versus GBP0.26 reported last year. Revenue for the quarter came in at GBP5.56 billion, versus GBP6.62 billion reported last year.

Full year 2014 core EPS now expected to be broadly similar to 2013, from prior growth expectations of 4 to 8 percent.

For earnings history and earnings-related data on GlaxoSmithKline (GSK) click here.